Regulatory News
Tuesday, November 15, 2016
BRIEF-Ignyta announces EAP Designation and CE Marking for its Trailblaze Pharos clinical trial assay
* Ignyta announces EAP Designation and CE Marking for its
Trailblaze Pharos(TM) clinical trial assay
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment